Policies ana Procedures — Page 3 
Special Fellowships are awarded for two-year periods. Two-year awards will be made up 
to $15,000 for the first year and $16,000 for the second year. The total amount of a 
Special Fellowship award, including fringe benefits and eight percent overhead, will not 
exceed $31,000. Under special circumstances, the Society may award a reduced Special 
Fellow grant for a shorter period of time. 
Special Fellowships are not renewable, although applications may be made for Scholar- 
ship status after at least one year as a Special Fellow. 
Only one Special Fellow award will be made at any one institution in any one year. 
FELLOW PROGRAM: Fellows of the Leukemia Society of America, Inc. are promising young 
investigators assisting and being trained by physicians and other scientists working in 
fields relevant to leukemia. Fellows are encouraged to embark on an academic career 
involving clinical or fundamental research in or related to leukemia, and should show 
evidence of a particular Interest in leukemia or related disorders. 
Fellowships are awarded for two-year periods. Two-year awards will be made up to $12,000 
for the first year and $13,000 for the second year. The total amount of a Fellowship 
award. Including fringe benefits and eight percent overhead, will not exceed $25,000. 
Under special circumstances, the Society may award a reduced Fellow grant for a shorter 
period of time. 
Fellowships are not renewable, although applications may be made for Special Fellowship 
status after at least one year as a Fellow. 
Only two Fellow awards will be made at any one institution in any one year. 
TERMS OF THE GRANTS 
1. The funds given pursuant to this grant application shall be used solely for the pur- 
poses specified in the application submitted to the Society as executed by the candidate 
and sponsor and in strict compliance with the budget annexed to said application. Grant 
periods normally run from July 1 to June 30 for each year of the grant. In special cir- 
cumstances, the Medical and Scientific Advisory Committee may approve an alternate date 
on which funding will start, provided permission has been obtained in advance. All grants 
shall be activated within the calendar year for which the application is approved. Other- 
wise it must be resubmitted and will have to compete on an equal basis with new grant 
applications when they are reviewed by the Committee the following year. 
2. The title, "Leukemia Society of America Scholar," (or Special Fellow or Fellow, as 
applicable) shall be used in all faculty titles and publications during the periods of the 
grant. Identification with the Leukemia Society of America, Inc. shall be made also in 
any "news" released about the Grantees by the Public Relations department of the sponsoring 
institution. 
3. In the event that the Grantee desires to transfer to another institution while the 
grant is in effect, continuation of the funding in the new institution will be allowed 
only with the written approval of the Medical and Scientific Advisory Committee. To 
obtain permission for relocation, the Grantee and Sponsor also shall submit letters to 
the Committee at least 90 days prior to the projected move outlining the advantages 
of the move and its effect on the progress of the project involved, particularly in its 
relationship to the field of leukemia research. An accounting of disbursements of the 
grant funds by the original sponsoring institution to the proposed date of transfer must 
accompany the request. A letter of recommendation from the new Sponsor who will 
supervise the Grantee's on-going work, and a new budget from the administrative office 
of that institution will be required. Also, if the proposed work differs from that 
originally approved, a complete description of the new project should be included. 
Only one transfer per institution per year will be allowed. 
[2091 
